{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:47:26Z","timestamp":1755794846422,"version":"3.44.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,16]]},"DOI":"10.7759\/cureus.90223","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T14:17:57Z","timestamp":1755353877000},"source":"Crossref","is-referenced-by-count":0,"title":["Uncommon Manifestations of Newly Diagnosed B-cell Chronic Lymphocytic Leukemia Prompting the Concurrent Diagnosis of Advanced Prostate Cancer: A Case Report"],"prefix":"10.7759","author":[{"given":"Christos","family":"Stafylidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iraklis","family":"Patsialos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Stefanou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleftheria","family":"Lakiotaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Diamantopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2016.06.003","article-title":"Chronic lymphocytic leukaemia","volume":"104","author":"Scarf\u00f2 L","year":"2016","unstructured":"Scarf\u00f2 L, Ferreri AJ, Ghia P. Chronic lymphocytic leukaemia. Crit Rev Oncol Hematol. 2016, 104:169-82. 10.1016\/j.critrevonc.2016.06.003","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.5398","article-title":"Other malignancies in chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"27","author":"Tsimberidou AM","year":"2009","unstructured":"Tsimberidou AM, Wen S, McLaughlin P, et al.. Other malignancies in chronic lymphocytic leukemia\/small lymphocytic lymphoma. J Clin Oncol. 2009, 27:904-10. 10.1200\/JCO.2008.17.5398","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2023.24.6.1971","article-title":"Evaluation of second primary cancer risk among chronic lymphocytic leukemia patients: Multicenter study","volume":"24","author":"Sayin S","year":"2023","unstructured":"Sayin S, Kiliacslan E, Yildirim M, et al.. Evaluation of second primary cancer risk among chronic lymphocytic leukemia patients: Multicenter study. Asian Pac J Cancer Prev. 2023, 24:1971-7. 10.31557\/APJCP.2023.24.6.1971","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.08.055","article-title":"Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia","volume":"53","author":"Mehrany K","year":"2005","unstructured":"Mehrany K, Weenig RH, Lee KK, Pittelkow MR, Otley CC. Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. J Am Acad Dermatol. 2005, 53:1067-71. 10.1016\/j.jaad.2005.08.055","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1975.03250030023012","article-title":"Subsequent neoplasia in chronic lymphocytic leukemia","volume":"232","author":"Manusow D","year":"1975","unstructured":"Manusow D, Weinerman BH. Subsequent neoplasia in chronic lymphocytic leukemia. JAMA. 1975, 232:267-9.","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v98.6.1979","article-title":"Solid tumors after chronic lymphocytic leukemia","volume":"98","author":"Hisada M","year":"2001","unstructured":"Hisada M, Biggar RJ, Greene MH, Fraumeni JF Jr, Travis LB. Solid tumors after chronic lymphocytic leukemia. Blood. 2001, 98:1979-81. 10.1182\/blood.v98.6.1979","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.957203","article-title":"Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: Distribution and clinical outcomes","volume":"56","author":"Benjamini O","year":"2015","unstructured":"Benjamini O, Jain P, Trinh L, et al.. Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: Distribution and clinical outcomes. Leuk Lymphoma. 2015, 56:1643-50. 10.3109\/10428194.2014.957203","journal-title":"Leuk Lymphoma"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1620941","article-title":"Risk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survival","volume":"60","author":"Ishdorj G","year":"2019","unstructured":"Ishdorj G, Beiggi S, Nugent Z, et al.. Risk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survival. Leuk Lymphoma. 2019, 60:3204-13. 10.1080\/10428194.2019.1620941","journal-title":"Leuk Lymphoma"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2020-140042","article-title":"Risk of secondary malignancy in CLL patients treated with novel targeted agents","volume":"136","author":"Eversman A","year":"2020","unstructured":"Eversman A, Cao S, Boughan KM, et al.. Risk of secondary malignancy in CLL patients treated with novel targeted agents. Blood. 2020, 136:46-7.","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0987-6","article-title":"Second cancer incidence in CLL patients receiving BTK inhibitors","volume":"34","author":"Bond DA","year":"2020","unstructured":"Bond DA, Huang Y, Fisher JL, et al.. Second cancer incidence in CLL patients receiving BTK inhibitors. Leukemia. 2020, 34:3197-205. 10.1038\/s41375-020-0987-6","journal-title":"Leukemia"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.366","article-title":"Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome","volume":"3","author":"Shen Y","year":"2021","unstructured":"Shen Y, Coyle L, Kerridge I, et al.. Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome. EJHaem. 2021, 3:129-38. 10.1002\/jha2.366","journal-title":"EJHaem"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00784-z","article-title":"Risk of second primary malignancies in patients with chronic lymphocytic leukemia: A population-based study in the Netherlands, 1989-2019","volume":"13","author":"van der Straten L","year":"2023","unstructured":"van der Straten L, Levin MD, Dinnessen MA, et al.. Risk of second primary malignancies in patients with chronic lymphocytic leukemia: A population-based study in the Netherlands, 1989-2019. Blood Cancer J. 2023, 13:15. 10.1038\/s41408-023-00784-z","journal-title":"Blood Cancer J"},{"key":"ref13","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Chronic Lymphocytic Leukemia\/Small Lymphocytic Lymphoma. Version 3.2025. (2025). Accessed: August 10, 2025: https:\/\/www.nccn.org\/guidelines\/category_1."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/395716-uncommon-manifestations-of-newly-diagnosed-b-cell-chronic-lymphocytic-leukemia-prompting-the-concurrent-diagnosis-of-advanced-prostate-cancer-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T14:17:58Z","timestamp":1755353878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/395716-uncommon-manifestations-of-newly-diagnosed-b-cell-chronic-lymphocytic-leukemia-prompting-the-concurrent-diagnosis-of-advanced-prostate-cancer-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.90223","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,16]]}}}